PedAM
Pediatric Disease Annotations & Medicines
| Disease | pleural effusion disorder |
| Phenotype | C0023470|myelogenous leukemia |
| Sentences | 2 |
| PubMedID- 20191333 | Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase. |
| PubMedID- 20463821 | The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: a literature-based economic analysis. |
Page: 1